Sentry Petroleum Ltd

Sentry Petroleum Ltd., an exploration stage company, acquires, explores, and develops oil and gas properties. It holds 100% interests in 4 exploration permits, including ATP 862, 864, 865, and 866 covering an area of approximately 6.9 million net acres located in the Adavale Basin, Queensland. The company was formerly known as Summit Exploration Inc. and changed its name to Sentry Petroleum Ltd. in December 2007. Sentry Petroleum Ltd. was founded in 2006 and is based in Denver, Colorado.

Sentry Petroleum Ltd trades as SPLM on OTC. The company is classified in Healthcare / Drug Manufacturers - Specialty & Generic and reports in USD.

The current profile places the business in Drug Manufacturers - Specialty & Generic. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $0 of revenue and -$128,912 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Sentry Petroleum Ltd can be compared against peers such as Aeolus Pharmaceuticals, Inc., CannTrust Holdings Inc., DrazCanna, Inc., Halo Collective Inc., Lowell Farms Inc., MPX International Corporation.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $4,745, beta of 20.58, and return on equity of +31.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SPLM currently shows total debt of $0 and beta of 20.58. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: D/A (2025-11-06 00:00:00), D/A (2025-10-30 00:00:00), D/A (2025-10-23 00:00:00), D (2025-02-04 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: http://www.stemsy.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.